欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/1238/002
药品名称Omeprazole 20mg/15ml Oral Solution
活性成分
    • Omeprazole 20.0 mg/15ml
剂型Oral solution
上市许可持有人Proveca Pharma Limited, 2 Dublin Landings, North Wall Quay, Dublin 1, D01 V4A3, Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Estonia (EE)
    • Czechia (CZ)
      Lappoxo 20 mg/15 ml perorální roztok
    • Slovakia (SK)
    • Germany (DE)
      Appizmit 20 mg/15 ml Lösung zum Einnehmen
    • Denmark (DK)
      Lappoxo
    • Belgium (BE)
    • Italy (IT)
    • Austria (AT)
    • Greece (GR)
    • Norway (NO)
    • Sweden (SE)
    • Poland (PL)
      Lappoxo
    • Finland (FI)
    • Latvia (LV)
    • Lithuania (LT)
许可日期2024/05/29
最近更新日期2025/08/07
药物ATC编码
    • A02BC01 omeprazole
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase